News FDA grants fast review for Roche's haemophilia drug Emicizumab is firm's latest blockbuster hopeful
News Novo's semaglutide outperforms Lilly GLP-1 rival If approved semaglutide could become set the standard for GLP-1 therapy
News Novo Nordisk may drop US insulin price as Sanofi suffers Biosimilar Lantus is causing rivals to cut prices to compete
News Novo Nordisk and Glooko launch diabetes management app New digital health partners Novo Nordisk and Glooko have released their first joint diabetes-focused app.
News Novo's Saxenda label to include cardio data Label will reflect heart benefit seen in LEADER trial.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
